Using a screen to identify human genes that promote pseudohyphal conversion in Saccharomyces cerevisiae, we obtained a cDNA encoding hsRPB7, a human homologue of the seventh largest subunit of yeast RNA polymerase II (RPB7). Overexpression of yeast RPB7 in a comparable strain background caused more pronounced cell elongation than overexpression of hsRPB7. hsRPB7 sequence and function are strongly conserved with its yeast counterpart because its expression can rescue deletion of the essential RPB7 gene at moderate temperatures. Further, immuno-precipitation of RNA polymerase II from yeast cells containing hsRPB7 revealed that the hsRPB7 assembles the complete set of 11 other yeast subunits. However, at temperature extremes and during maintenance at stationary phase, hsRPB7-containing yeast cells lose viability rapidly, stress-sensitive phenotypes reminiscent of those associated with deletion of the RPB4 subunit with which RPB7 normally complexes. Two-hybrid analysis revealed that although hsRPB7 and RPB4 interact, the association is of lower affinity than the RPB4-RPB7 interaction, providing a probable mechanism for the failure of hsRPB7 to fully function in yeast cells at high and low temperatures. Finally, surprisingly, hsRPB7 RNA in human cells is expressed in a tissue-specific pattern that differs from that of the RNA polymerase II largest subunit, implying a potential regulatory role for hsRPB7. Taken together, these results suggest that some RPB7 functions may be analogous to those possessed by the stress-specific prokaryotic sigma factor rpoS.
Using a screen to identify human genes that promote pseudohyphal conversion in Saccharomyces cerevisiae, we obtained a cDNA encoding hsRPB7, a human homologue of the seventh largest subunit of yeast RNA polymerase II (RPB7). Overexpression of yeast RPB7 in a comparable strain background caused more pronounced cell elongation than overexpression of hsRPB7. hsRPB7 sequence and function are strongly conserved with its yeast counterpart because its expression can rescue deletion of the essential RPB7 gene at moderate temperatures. Further, immuno-precipitation of RNA polymerase II from yeast cells containing hsRPB7 revealed that the hsRPB7 assembles the complete set of 11 other yeast subunits. However, at temperature extremes and during maintenance at stationary phase, hsRPB7-containing yeast cells lose viability rapidly, stress-sensitive phenotypes reminiscent of those associated with deletion of the RPB4 subunit with which RPB7 normally complexes. Two-hybrid analysis revealed that although hsRPB7 and RPB4 interact, the association is of lower affinity than the RPB4-RPB7 interaction, providing a probable mechanism for the failure of hsRPB7 to fully function in yeast cells at high and low temperatures. Finally, surprisingly, hsRPB7 RNA in human cells is expressed in a tissue-specific pattern that differs from that of the RNA polymerase II largest subunit, implying a potential regulatory role for hsRPB7. Taken together, these results suggest that some RPB7 functions may be analogous to those possessed by the stress-specific prokaryotic sigma factor rpoS.
INTRODUCTION
Transcription of messenger RNAs in eukaryotes must be responsive to a large number of complex intracellular and environmental signals that affect many cell processes, including control of cell division, specification of morphology, and response to stress. To begin to understand how signals selectively influence the expression of genes involved in fundamental cell processes, much work has been directed toward understanding how transcription factors orchestrate the actions of basal transcrip-polymerases is well conserved in eukaryotes. The genes encoding all 12 Saccharomyces cerevisiae pol II subunits, designated RPB1-RPB12, have been cloned and characterized (Young, 1991; Treich et al., 1992; . A number of lines of evidence indicate that two of the subunits, RPB4 and RPB7, may play a ar-like role that is specifically required for stress response. First, in actively growing yeast cells, approximately 20% of pol II is purified as a species containing all 12 subunits, whereas 80% lacks the stable RPB4-RPB7 subcomplex (Edwards et al., 1991) . In yeast that are at stationary phase, a marked shift in the assembly of the RPB4-RPB7 subcomplex with pol II occurs, resulting in virtually 100% assembly of the subcomplex (Choder and Young, 1993) . Second, yeast strains with null alleles for RPB4 (rpb4-strains) are inviable at low and high temperatures, and lose viability much more rapidly than wild-type yeast when kept at stationary phase (Woychik and Young, 1989; Choder and Young, 1993) . This is attributable to transcription defects, as mRNA synthesis in rpb4-yeast declines rapidly after heat shock or during shift to stationary phase growth relative to RPB4+ yeast (Choder and Young, 1993) . Third, yeast overexpressing RPB4 grow more rapidly than wild-type yeast during post-logarithmic growth phases (Choder, 1993) . In sum, these results suggest that the RPB4/RPB7 complex increases the resistance of RNA polymerase II to stress, and thus contributes to organismal survival under inclement growth conditions.
We report here the isolation of a human RPB7 homologue hsRPB7 through a genetic screen in S. cerevisiae similar to that recently described by Gimeno and Fink (1994) . Overexpression of hsRPB7 and, more pronouncedly, yeast RPB7 leads to enhanced production of pseudohyphae during growth on nitrogen-limited media. hsRPB7 complements rpb7-yeast strains at moderate temperatures. However, cells growing under control of hsRPB7 rapidly lose viability after culture at temperature extremes, and during maintenance at stationary phase. hsRPB7 assembles with the complete set of yeast pol II subunits and directly interacts with RPB4, although with lower affinity than the RPB7-RPB4 interaction in wild-type yeast cells. hsRPB7 is expressed in a highly tissue-specific manner in human cells, in a pattern that differs from that of the largest subunit of pol II. Cumulatively, our data indicate that an essential RPB7 function is conserved from yeast through humans, and that the subunit may selectively associate with pol II to regulate its function.
MATERIALS AND METHODS Bacteria and Yeast Strains
The Escherichia coli strain DH5aF' [F'/endAl hsdR17(rK-mK+)supE44
thi-1 recAl gyrA (Nalr) relAl A(lacZYA-argF) U169 (4.8OlacA(lacZ) M15)] was used as a host for all cloning constructions. The S. cerevisiae strain CGx74 [MAT a/cdrp1::his6ltrpl::his6 1, similar to CGx31 and congenic with the S1278b genetic background (Grenson et al., 1966) 
Sequence Analysis
Both strands of the hsRPB7 gene were sequenced using oligonucleotide primers to the JG4-4 vector and to internal hsRPB7 sequence in combination with the Sequenase system (United States Biochemical, Cleveland, OH). Database searching was performed using the BLAST algorithm (Altschul et al., 1990) (Devereux et al., 1984) .
Plasmid Constructions
To construct pEG202-hsRPB7, the original JG4-4-hsRPB7 clone was digested with EcoRI and XhoI, and cloned into the vector pEG202ATT (a derivative of pEG202 (Golemis et al., 1994) modified so that the reading frame from EcoRI corresponds to ATT; Golemis, unpublished data) that had similarly been digested with EcoRI and XhoI. The resulting clone encoded a fusion protein in which the LexA coding sequences were followed by the sequence NSARG-GTLPAYLVWE followed by the hsRPB7 coding sequences.
To The LexA-operator-LacZ reporter has been described (Golemis et al., 1994) . Briefly, it is a derivative of LRlAl (West et al., 1984) containing the 2 ,um origin of replication and the URA3 selectable marker for propagation in yeast, and constructed so that four copies of LexA operator motifs derived from the colEl promoter (Ebina et al., 1983) are located upstream of the GALl minimal promoter and the LacZ coding sequences.
The plasmid pRP729 has an -1.4-kb RPB7-containing fragment with -600 bp 5' BamHI ends and -300 bp 3' Sall ends cloned into the BamHI/SalI sites of the URA3/CEN-ARS vector pRS416 (Sikorski and Hieter, 1989) . pRP730 has the -1.4 kb BamHI/SalI insert from pRP729 cloned into the BamHI/SalI sites of the HIS3/CEN-ARS plasmid pRS413 (Sikorski and Hieter, 1989) . To construct plasmid pRP731, the RPB7 coding sequences of pRP730 were exactly replaced with those of hsRPB7 using a two step polymerase chain method (PCR) method (Dillon and Rosen, 1990 
Plasmid Shuffle
The yeast strains containing the yeast RPB7 HIS3 plasmid and the hsRPB7 plasmid (WY-75) were obtained by selecting against the wild-type RPB7 URA3 plasmid using 5-fluoroorotic acid (Boeke et al., 1987 (Samson et al., 1989) using polyclonal antiserum specific for LexA (Brent and Ptashne, 1984) or for hemagglutinin (Babco, Rich- mond, CA), as appropriate. and LexA-hsRPB7 were expressed to comparable levels. Activation of the LacZ reporter was determined as previously described (Brent and Ptashne, 1985) ; ,3-galactosidase assays were performed on three independent colonies, on three separate occasions, and values for particular plasmid combinations varied less than 25%. Activation of the LEU2 reporter was determined by observing the colony-forming ability of yeast plated Vol. 6, July 1995 on complete minimal medium lacking leucine. The LexA-PRD/HD expressing plasmid has been described (Golemis and Brent, 1992 (Kolodziej and Young, 1991) , using SWG16 antibody specific to the carboxy terminal domain of the RPB1 subunit (Thompson et al., 1990; Treich et al., 1992) . Immunoprecipitated subunits were resolved by electrophoresis on a 12% sodium dodecyl sulfate-polyacrylamide gel. Gels were fixed in 30% methanol, 10% glacial acetic acid, treated with Enlightning (Dupont, Wilmington, DE), and exposed on Kodak AR film for 1-2 days. Additional quantitation was done using a Fuji Bioanalyzer.
Northern Analysis
The synthetic oligonucleotide EG53 (AGC AAG TTG GGG CCG AAG) was used as a probe for hsRPB7 expression. The synthetic oligonucleotide EG33 (CAG TTC ATC CGG ACT CAG GAC TCC G) was used as a probe for hsRPBl expression. Oligos were radioactively labeled using T4 polynucleotide kinase and crude [^y-32P]ATP (ICN Radiochemical, Cleveland, OH) . The multiple tissue Northem blots, MTN1 and MTN2, were purchased from Clontech (Palo Alto, CA) and had been previously normalized to within threefold variation of mRNA levels using an actin probe. Additionally, we have stripped and rehybridized them with a probe for another gene, HEF3 (Golemis, unpublished data) , and observed less than threefold variation in signal intensity between lanes. Hybridizations were carried out as described in (Ausubel et al., 1987 (Ausubel et al., -1994 . Selective temperature washes were done at 50°C; blots were exposed on Kodak AR film at -70°C for 2-10 days, and were subsequently quantitated using a Fuji Bioanalyzer.
Generation of Polyclonal Antibodies hsRPB7 was excised from vector JG4-4 using EcoRI and XhoI, and cloned into similarly restricted plasmid pGEX (Pharmacia, Piscataway, NJ) to create a glutathione-S-transferase (GST) fusion protein. This plasmid was transformed into bacterial strain CAG456, and expression of protein was induced by standard means with IPTG (Ausubel et al., 1987 (Ausubel et al., -1994 . Induced bacteria were pelleted, resuspended in 2x Laemmli sample buffer (10% ,3-mercaptoethanol, 6% SDS, 20% glycerol, and 0.2 mg/ml bromphenol blue) and lysed by sonication, and the GST-hsRPB7 fused protein purified by resolution on a 10% polyacrylamide gel. The GST-hsRPB7-fused protein was visualized by aqueous Coomassie blue staining, excised from the gel, and used to inject two rabbits, following a standard schedule of boosts and bleeds (Ausubel et al., 1987 (Ausubel et al., -1994 .
Western Analysis
Yeast lysates were prepared from logarithmically growing cultures as previously described (Samson et al., 1989) . For mammalian cell lysates, HeLa human cervical carcinoma cells (ATCC CCL2), 293 human primary embryonal kidney cells (ATCC CRL 1573), Jurkat human acute T cell leukemia cells (ATCC TIB152), Huh6 and Huh7 human hepatoma cells (Nakabayashi et al., 1982) , passage 10 foreskin fibroblast cells (Repository No. GM08333A; Weiss et al., 1989) , and PANC-1 pancreatic epithelial carcinoma (Lieber et al., 1975) were grown in recommended standard media to -80% confluence. Adherent cells were trypsinized to remove them from plates. Cells from a single 10-cm plate were pelleted, and resuspended in 300 ,ul ice cold 0.25 M Tris-HCl, pH 7.4. Two hundred microliters of this suspension was immediately removed and mixed with 50 jl of 8x
Laemmli sample buffer, frozen in a dry ice ethanol bath, and stored at -70°C until use. The remaining 100 ,ul of suspension cells were lysed by three freeze-thaw cycles, and used for quantitation of protein concentration by Lowry assay (Lowry et al., 1951) . Lysates frozen in 2x Laemmli buffer were thawed, sonicated briefly, and 50 ,ug of protein for each cell line were resolved on two SDS-polyacrylamide gels. One gel was blotted to nitrocellulose, and used for Western analysis. Visualization of RPB7 and hsRPB7 proteins was performed using 1:2000 dilutions of rabbit polyclonal antibodies to either LexA or hsRPB7 or preimmune serum from GST-hsRPB7-injected rabbits as a primary antisera (as described in RESULTS), and a 1:1000 dilution of alkaline-phosphatase-conjugated goat antirabbit antibodies (Sigma, St. Louis, MO) as a secondary detection system. The second gel was stained with Coomassie blue, and used to confirm that comparable quantities of proteins had been loaded, and that no protein degradation had occurred. Gels were 10% or 12% polyacrylamide, as described in RESULTS.
RESULTS
Overexpression of hsRPB7 Influences S. cerevisiae Cell Morphology To identify proteins that regulate the morphology and polarity of human cells, we screened a human cDNA library for genes that enhanced formation of pseudohyphae when expressed in the yeast S. cerevisiae. S. cerevisiae undergoes a dimorphic shift in response to severe nitrogen limitation that involves changes in budding pattern, cell cycle control, cell elongation, and invasive growth into agar . A galactose-inducible HeLa cell cDNA library was used to transform a yeast strain that can form pseudohyphae on nitrogen-restricted media, and a number of human genes that specifically enhanced pseudohyphal formation were identified. One of the cDNAs derived from this screen was found to cause longer filamentous projections of diploid yeast grown on low-nitrogen media, and to lead to the production of a greater number of projections per microcolony ( Figure  1 ). In contrast, expression of this cDNA had no effect on cell morphology in haploid yeast, or in yeast grown on rich media (our unpublished results). Analysis of the sequence of this gene (Figure 2 ) revealed that it was a novel human gene with strong sequence similarity to the yeast RPB7 gene (Figure 2 ). The predicted isoelectric point of the hsRPB7 protein occurs at pH 5.3, and reflects the presence of acidic residues predominantly located at the C-terminal end of the protein. Inspection of the protein sequence reveals a number of good potential phosphorylation sites for casein kinase II, as well as two potential phosphorylation sites for protein kinase C, although whether these sites are phosphorylated in vivo remains an open question. The yeast RPB7 subunit does not appear to be phosphorylated (Kolodziej et al., 1990) , and diverges from hsRPB7 at most of the possible casein kinase II and protein kinase C consensus sites. hsRPB7 sequence information has been filed with GenBank (accession number U20659).
Comparison of the predicted hsRPB7 coding sequence to the GenBank database using the BLAST algorithm (Altschul et al., 1990 ) revealed significant homology to a family of RNA polymerase subunits of which the most well characterized member is the yeast RPB7 subunit (Figure 3, A and B) . hsRPB7 possesses 43% identity (63% similarity) to RPB7, and 53% identity (76% similarity) to the fifth largest subunits of the RNA polymerases of Glycine max (soybean) and Arabidopsis thaliana (Ulmasov and Guilfoyle, 1992 quence is closer to yeast and plant than they are to each other. Although more distantly related, hsRPB7 also possessed 21% identity (48% similarity) to the yeast YKL1 gene (Abraham et al., 1992) , which has recently been shown to encode the C25 subunit of yeast RNA polymerase III (Pati and Weissman, 1990; Sadhale and Woychik, 1994) , and 21% identity (44% similarity) to the rpoE subunit of the archaebacterium Sulfolobus acidocaldarius (GenBank accession number X75411). The conservation of sequence through such an evolutionarily divergent group of organisms suggests an important function for the RPB7 family of proteins. Finally, although the sequence similarity between this group of proteins extends through the entire length of sequence, it is most pronounced in the region extending from amino acid residues -70-90 of the hsRPB7 sequence. This conserved domain is essential for RPB7 and C25 function in S. cerevisiae because deletion of this region resulted in lethality (Sadhale and Woychik, 1994) , and likely serves an important role in human cells as well.
Overexpression of RPB7 also Alters S. cerevisiae Cell Morphology, but Overexpression of RPB4 Does Not Because we were surprised to isolate a pol II subunit in a screen expected to yield regulators of cell morphology, we wanted to verify the physiological significance of this result by testing whether RPB7 could similarly enhance pseudohyphae in yeast. We overexpressed the yeast RPB7 gene from the same galactoseinducible expression vector used to clone hsRPB7, and compared pseudohyphal formation by hsRPB7, RPB7, or vector-containing CGx74 (Figure 4) . Cell elongation and adaptation of a unipolar budding pattern was notably more pronounced with the yeast RPB7 than with the human hsRPB7, suggesting that the phenotype was not the result of hsRPB7 interfering with RPB7 function.
RPB7 has been shown to form a highly stable subcomplex with the yeast RPB4 subunit (Edwards et al., 1991; Young, 1991) . This subcomplex appears to play a key role in enabling yeast survival during periods of stress and during stationary phase (Choder, 1993; Choder and Young, 1993) . As RPB4 function might potentially be relevant for growth on the severely nitrogen-limited medium used to establish pseudohyphal growth, we tested whether overexpression of RPB4 by itself was sufficient to induce pseudohyphal growth, or whether co-expression of RPB4 with hsRPB7 or RPB7 would affect pseudohyphal growth induced by these genes ( Figure 5 and our unpublished results). We found that RPB4 overexpression did not by itself induce expression of pseudohyphae ( Figure 5 , A and D). Further, co-expression of RPB4 with RPB7 ( Figure 5 , E and H) or hsRPB7 (our unpublished results) neither enhanced nor reduced pseudohyphal induction by RPB7.
hsRPB7 Can Complement RPB7 Deletion Strains at Moderate Temperatures Because the amino acid sequence of the hsRPB7 protein is well conserved from humans to yeast, we wanted to determine if hsRPB7 can functionally substitute for S. cerevisiae RPB7. Using the plasmid shuffle method (Boeke et al., 1987) , we tested whether expression of hsRPB7 was able to rescue the lethality associated with an RPB7 null mutation . Yeast cells that have the chromosomal copy of RPB7 disrupted by insertion of the LEU2 gene plus a wildtype complementing copy of the RPB7 gene on a URA3 plasmid were transformed with an additional HIS3 plasmid, containing either hsRPB7 under the control of the RPB7 promoter or the RPB7 gene and its promoter. Ura+His Leu+ transformants were transferred to media containing 5-fluoroorotic acid to select for loss of the yeast RPB7/URA3 plasmid. Both the yeast RPB7 control plasmid and the hsRPB7 plasmid supported wild-type levels of yeast cell growth at moderate temperatures ( Figure 6A) with the difference most pronounced at 37°C ( Figure  6B ). hsRPB7 yeast also grew more poorly than RPB7 yeast at 12°C, although the difference was less pronounced.
Although overexpression of RPB4 did not affect enhancement of pseudohyphal growth by RPB7, the defects seen in hsRPB7 yeast cells, including conditional lethality at high and low temperatures and stationary phase defects, were similar to those seen with rpb4-mutations (Choder and Young, 1993) . We therefore tested an additional parameter associated with the lack of the RPB4 gene, reduced resistance to heat shock (Choder and Young, 1993) . Cultures of hsRPB7 and RPB7 expressing yeast were grown at 30°C, then exposed to timed heat shock at 42°C. Yeast expressing RPB7 remained fully viable for at least 7 h at 42°C, whereas yeast expressing hsRPB7 rapidly lost viability and became completely inviable between 3 and 5 h of heat shock (our unpublished results). Because overexpression of RPB4 has been shown to increase growth rate of post-logarithmic growth phase cultures (Choder, 1993) , we wanted to test whether overexpression of hsRPB7 or RPB7 affected growth rates as well. If so, these genes might be contributing to pseudohyphal development by stimulating cell growth. We compared growth rate at 30°C in SLAHGR (low nitrogen) medium of CGx74 yeast overexpressing hsRPB7 or RPB7 to that of control CGx74 yeast expressing JG4-4 vector ( Figure 7 ). Lag time before commencement of cell division, doubling time, and saturation density were similar for all three cultures: overexpression of RPB7 may have marginally decreased growth rate, although the decrease was within the limit of experimental variation. In contrast to the loss of viability observed after long-term culture in yeast growing under control of hsRPB7 ( Figure 6B ), yeast overexpressing hsRPB7 and RPB7 maintained viability similar to control yeast after incubation for >96 h in SLAGHR medium. These data exclude a role for overexpression of RPB7 in increasing growth rate or inducing severe toxicity on low nitrogen medium.
hsRPB7 Associates with Yeast RPB4 The above data indicated that hsRPB7 could complement the essential function of RPB7, but might be deficient in its ability to interact with RPB4 or another protein in the transcription complex. To directly test this hypothesis, we utilized a two-hybrid/interaction trap approach (Fields and Song, 1989; Gyuris et al., 1993; Golemis et al., 1994) . We used the constitutive ADH promoter to express hsRPB7 and RPB7 as fusions to the DNA binding protein LexA, and the galactose-inducible GALl promoter to express RPB4 as a fusion to a transcriptional activation domain. We transformed these constructions and a negative control (LexA fused to the PRD box and homeodomain of bicoid (Gyuris et al., 1993) ) together with a LexA operator-LacZ reporter into yeast, and compared activation of the reporter by LexA-RPB7, LexA-hsRPB7, and LexA-PRD/HD in the presence or the absence of the activation domain-fused RPB4 protein. Both hsRPB7 and RPB7 interacted with RPB4 in yeast, while the negative control protein did not (Table 1) . However, the degree of enhancement of activation as quantitated by ,B-galactosidase assay was considerably greater for the RPB4-RPB7 combination than for the hsRPB7-RPB4 combination (60-fold versus 2-to 3-fold). These results indicate that hsRPB7 is able to interact with RPB4 in vivo, but does so with a lower affinity than the RPB4-RPB7 subunit pair.
hsRPB7 Assembles with Yeast RNA Polymerase II Subunits Previous work has shown that RPB7 does not appear to immunoprecipitate with RNA pol II in yeast lacking RPB4 (Kolodziej et al., 1990) . Because rpb7-yeast are inviable, it has been impossible to determine whether RPB7 is required for RPB4 to associate stably with pol II. Because our data suggested that hsRPB7 associated poorly with RPB4, one possible explanation for the rpb4--like defects of hsRPB7 yeast was that RPB4/ hsRPB7 was unable to assemble with the remainder of the pol II subunits. Alternatively, hsRPB7/RPB4 could associate with the remainder of the pol II subunits, but result in a complex that was not fully functional. To discriminate these possibilities, we immunoprecipitated 35S-labeled pol II from RPB7-or hsRPB7-expressing yeast using an antibody to the carboxy terminal domain of the largest subunit of pol II (Figure 8 ), resolving individual subunits by SDS-polyarylamide gel electrophoresis (PAGE). Quantitation of the stoichiometry of precipitated subunits from the two species was identical, indicating that hsRPB7 is able to assemble as efficiently as its yeast counterpart with the full set of yeast pol II subunits, including RPB4.
Tissue-specific Expression of hsRPB7 RNA We examined the expression levels of hsRPB7 mRNA in different human tissues using Northern blot analysis ( Figure 9A ). The hsRPB7 probe hybridized to a single band of approximately 800 bp, which together with the presence of homology to the full length of RPB7 coding sequence indicates that the hsRPB7 cDNA isolated in the screen is full length or close to full length. Surprisingly, however, the hsRPB7 mRNA fluctuated drastically between tissues, being expressed at very high steady-state levels in heart, muscle, kidney, and liver, and at much lower levels in other tissues. Direct quantitation of 32p label using a Fuji Bioanalyzer indicated as much as an 80-to 90-fold variation between high and low end values.
This difference in steady-state hsRPB7 mRNA levels could reflect the abundance of transcripts encoding pol II subunits, or it could reflect differential levels of the hsRPB7 mRNA relative to the rest of the complex. To resolve these two possibilities, we stripped the multi-tissue blot and rehybridized with a probe specific for the largest subunit of human pol II , here designated hsRPB1 ( Figure 9B ). This probe hybridized specifically to a single transcript of -6.7 kb, corresponding to the reported size of the transcript encoding this subunit , that was present at similar levels in all tissues examined. Interestingly, placental tissue contained a single transcript of -7.5-8 kb, which might represent an alternately spliced form of the gene encoding the largest subunit. Strikingly, the steady-state levels of the hsRPB1 transcript differ substantially in tissue distribution relative to the hsRPB7 transcript. Although levels of hsRPB1 were somewhat elevated in kidney and muscle (although much less that the hsRPB7 transcript), they were extremely low in liver and heart. These data suggest that transcription or stability of the hsRPB7 mRNA is regulated differently than that of the largest pol II subunit, and imply that hsRPB7 might be differentially available to RNA polymerase II in different tissues.
Expression and Modification of hsRPB7 Protein
The yeast RPB7 protein migrates as a 17-18 kDa species on SDS-PAGE gels (Sentenac, 1985) , and is not post-translationally modified (Kolodziej et al., 1990) . We examined expression of the hsRPB7 protein in yeast and human cells using polyclonal antiserum raised against a GST-hsRPB7 protein fusion ( Figure  10 ). To confirm that this antiserum reacted specifically with hsRPB7 but not with RPB7, we used 10% polyacrylamide gels to resolve whole cell lysates of cells expressing either native RPB7 or hsRPB7 proteins, or LexA-fused RPB7 or hsRPB7. We probed triplicate blots of these resolved lysates with either antibody to LexA, antibody to GST-hsRPB7, or pre-immune serum from GST-hsRPB7 rabbits ( Figure 10A ). Antibody to LexA revealed similar expression levels of LexA-hsRPB7 and LexA-RPB7 fusion proteins (Figure 1OA , left two lanes in each panel), with LexAhsRPB7 migrating with a slightly higher molecular weight than LexA-RPB7. In contrast, antibody to hsRPB7 specifically detected LexA-hsRPB7. Using the same panel of antisera on WY74 (RPB7 only) and WY75 (hsRPB7 only) yeast extracts ( Figure 1OA , right two lanes of each panel), antibody to hsRPB7 detected a single protein migrating at approximately 24 kDa in lanes containing WY75 extracts, whereas neither of the other antisera recognized any specific proteins. In conHours RPB7, 300C HsRPB7, 300C RPB7, 370C HsRPB7, 370C trast, antibody to hsRPB7 detected two specific bands, one of 24 kDa and a second of 18 kDa, in a whole cell extract of 293 human embryonal kidney cells ( Figure  10A , central lane in first panel).
We then used the antiserum to hsRPB7 to compare protein expression in seven human cell lines, this time using a 12% polyacrylamide gel to increase resolution of lower molecular weight protein species ( Figure  10B ). In each case the antibody detected a species at 24 kDa and a species at 18 kDa. Abundance of both the 24 (Cho et al., 1985; Pati and Weissman, 1989; Pati and Weissman, 1990; Acker et al., 1992; Wintzerith et al., 1992; Acker et al., 1993; McKune and Woychik, 1994; Pati, 1994) . In general, the degree of evolutionary sequence conservation is quite high for all the subunits so far cloned. Of subunits tested to date, the human homologue has been able to at least partially complement the yeast equivalent in six cases (including hsRPB7) and not been able to in one other Woychik, unpublished data) .
Results from the two-hybrid, co-precipitation, and Western blot experiments described here suggest that a mechanism for the conditional complementation phenotype of hsRPB7 is the inability of RPB4 to complex appropriately with the 24-kDa form of hsRPB7. We derive this conclusion from the following data: 1) two-hybrid data indicate hsRPB7 and RPB4 appear to B hsRPB1 9.5-7. and RPB7 found in wild-type yeast, with hsRPB7 and RPB7 showing equivalent mobilities on resolving gels. In contrast, when hsRPB7 is synthesized in yeast, only a higher migrating (24 kDa) form is recognized by the hsRPB7. This 24-kDa form is probably the result of post-translational modification and appears to be the predominant form of hsRPB7 in yeast. We have excluded the possibility that our antibody preferentially recognizes this higher migrating form by control experiments in which antibody to LexA indicates LexAhsRPB7 predominantly migrates at a higher molecular mass than LexA-RPB7. Thus, under normal growth conditions in which RPB4 function is not necessary, hsRPB7 can fulfill the essential function of RPB7, and the small quantity of unmodified hsRPB7 present (which is apparently not abundant enough to be detectable by Western analysis) can assemble into pol II. Under stressful growth conditions, RPB4 is unable to execute its protective function in concert with hsRPB7, either because the two proteins do not associate in a manner leading to a functional complex, or because the unmodified 18-kDa species with which RPB4 can complex is limiting. It should be noted that although the proportion of pol II complexes containing RPB4 and RPB7 changes substantially during stationary phase and stress response, the overall levels of RPB4 RNA and protein remain constant (Choder, 1993) Blacketer et al., 1993 Blacketer et al., , 1994 or loss (Liu et al., 1993 ) of pseudohyphal expression, or whose overexpression leads to constitutive pseudohyphal expression (Gimeno and Fink, 1994) . Genes isolated by these means fall into a number of classes, including a facilitator of amino acid permease transport , kinases from the mating factor (Liu et al., 1993) and other signal transduction pathways (Blacketer et al., 1993) , and a transcription factor (Gimeno and Fink, 1994 ulated at numerous levels. While misexpression of other genes not known to be involved in regulation of pseudohyphal transition can result in cell elongation (Haarer and Pringle, 1987; Richardson et al., 1990) , several points seem to support a role for RPB7 as a contributory factor to pseudohyphal growth. First, the phenotype is specific to diploid yeast. Second, it is specific to growth on low-nitrogen plates. Third, the fact that the yeast RPB7 pseudohyphal effect is more pronounced than the human eliminates the possibility that cell elongation is due to a nonspecific derangement of normal growth controls because of aberrant transcription induced by pol II containing hsRPB7. Overexpression of neither hsRPB7 nor RPB7 appears to be toxic in yeast, in that yeast expressing high levels of RPB7 or hsRPB7 in a wild-type background grow as rapidly as control yeast under a variety of growth conditions. At this time, the simplest interpretation of these data is that the RPB4/RPB7 system, previously only shown to be required for stress survival, also contributes to cell elongation during pseudohyphal growth, a morphological change induced by the severe limitation of nitrogen in the growth medium , and enhanced by the presence of yeast mutations that intensify this nutritional stress .
Pseudohyphal cells have a greater cell size than cells growing normally, and are considerably elongated ; the combination of these changes with a conversion of budding pattern to unipolar allows colonies to spread over greater distance than normally dividing cells, a protective change that increases the likelihood of reaching a food source . A potentially interesting analogy can be derived from the prokaryotic system of selectively utilizing different a-factors in developmental programs (reviewed in Shapiro, 1993) or in stress response pathways (reviewed in Hengge-Aronis, 1993 ).
In particular, the rpoS gene of E. coli encodes os, a protein that has been shown to be specifically required for transcription of a series of genes required for successful entry into stationary phase. In normal transition to stationary phase, selective association of u-s with RNA polymerase leads to the expression of a large regulon of genes that cumulatively cause E. coli to convert their shape from a rodlike form to a smaller, more spherical form, and to become generally stressresistant (Hengge-Aronis, 1993) . In rpoS-mutant cells, there are general defects in the response to cell stress and reduced survival of stationary phase; strikingly, because of misregulation of the bolA gene, cell morphology is significantly affected, with rpoS-cells generally larger than wild-type cells, and displaying a series of morphologies ranging from long filaments to short rods (Lange and Hengge-Aronis, 1991) . The presence of the RPB4/RPB7 subcomplex in pol II has been demonstrated to alter polymerase initiation properties (Edwards et al., 1991) ; these properties may also include promoter selectivity, as some data on transcription patterns in rpb4-yeast would suggest (Choder, 1993; Choder and Young, 1993) . By the rpoS model, the development of excessive cell elongation in the presence of excess hsRPB7 and RPB7 is compatible with the idea that RPB7 may function as a stressorspecific ouS-like factor in lower and potentially higher eukaryotes, affecting a range of cell functions including control of cell morphology. The association of RPB7 with rpoS-like functions is consistent with current evidence that suggests that sigma-like functions are dispersed among several proteins in eukaryotes (Jaehning, 1991) Finally, a striking and unexpected finding of this study is the degree of complexity associated with hsRPB7 expression at the RNA and protein levels. The relative abundance of the hsRPB7 transcript varies drastically relative to that of the mRNA encoding the largest RNA pol II subunit in different tissues. Antibody to hsRPB7 detects multiple crossreacting proteins that are expressed at variable levels in different human cell lines. Because the RNA analysis was done with primary tissue, and the protein analysis with cultured cell lines, it is not possible to directly compare expression levels based on these data. For at least some tissues, the RNA and protein data show parallel trends, putting hsRPB7 expression higher in kidney tissue and kidney-derived 293 cells, and lower in pancreatic tissue and pancreas-derived PANC-1 cells. Subsequent analysis should clarify both the magnitude of variation of hsRPB7 protein expression, and the significance of this variation for biological function in vivo. A particularly intriguing question arising from the protein expression data is the role of the 24-kDa form of hsRPB7. One possibility is that this species corresponds to an inactive pool of hsRPB7 held in reserve; alternatively, this species may possess an entirely discrete function. In sum, our results raise the possibility that differing forms of RNA polymerase II, some with and some without associated hsRPB7, exist in different tissues, paralleling the existence of pools of pol II with and without the RPB4/RPB7 subcomplex noted in S. cerevisiae (Choder and Young, 1993) . If so, this might lend yet another twist to the complex field of higher eukaryotic transcriptional regulation.
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